Drug Information
Drug (ID: DG00598) and It's Reported Resistant Information
Type(s) of Resistant Mechanism of This Drug
EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-02: Benign/in-situ/malignant neoplasm
Mycosis fungoides [ICD-11: 2B01]
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Key Molecule: hsa-mir-155 | [1] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Disease | Mycosis fungoides [ICD-11: 2B01.0] | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | MyLa cells | Embryo | Homo sapiens (Human) | N.A. |
MJ cells | Peripheral blood | Homo sapiens (Human) | CVCL_1414 | |
In Vivo Model | SCID nude mouse xenograft model | Mus musculus | ||
Experiment for Molecule Alteration |
qRT-PCR | |||
Experiment for Drug Resistance |
Flow cytometry assay | |||
Mechanism Description | Oncogenic miR-155 appears to contribute to the cancerous phenotype of MyLa and MJ cells. | |||
Key Molecule: hsa-mir-155 | [1] | |||
Molecule Alteration | Expression | Up-regulation |
||
Resistant Disease | Mycosis fungoides [ICD-11: 2B01.0] | |||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | MyLa cells | Embryo | Homo sapiens (Human) | N.A. |
MJ cells | Peripheral blood | Homo sapiens (Human) | CVCL_1414 | |
In Vivo Model | SCID nude mouse xenograft model | Mus musculus | ||
Experiment for Molecule Alteration |
qRT-PCR | |||
Experiment for Drug Resistance |
Flow cytometry assay | |||
Mechanism Description | Oncogenic miR-155 appears to contribute to the cancerous phenotype of MyLa and MJ cells. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.